Mostrar el registro sencillo del ítem

dc.contributor.authorRozo Ortiz, Edwar Jassirspa
dc.contributor.authorVargas Rodriguez, Ledmar Jovannyspa
dc.contributor.authorAgudelo Sanabria, Milena Brigittespa
dc.date.accessioned2019-01-11 00:00:00
dc.date.accessioned2022-03-08T16:18:38Z
dc.date.available2019-01-11 00:00:00
dc.date.available2022-03-08T16:18:38Z
dc.date.issued2019-01-11
dc.identifier.issn2389-7325
dc.identifier.urihttps://repositorio.uniboyaca.edu.co/handle/uniboyaca/350
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.publisherUniversidad de Boyacáspa
dc.rightsRevista Investigación en Salud Universidad de Boyacá - 2019spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistasdigitales.uniboyaca.edu.co/index.php/rs/article/view/303spa
dc.subjectaspergilosis pulmonarspa
dc.subjectAspergillusspa
dc.subjectautoinmunidadspa
dc.subjectenfermedades autoinmunesspa
dc.subjectenfermedades pulmonares fúngicasspa
dc.subjectpulmonary aspergillosiseng
dc.subjectAspergilluseng
dc.subjectautoimmunityeng
dc.subjectautoimmune diseaseseng
dc.subjectfungal lung diseaseseng
dc.subjectaspergilose pulmonareng
dc.subjectAspergilluseng
dc.subjectautoimunidadeeng
dc.subjectdoenças autoimuneseng
dc.subjectdoenças pulmonares fúngicaseng
dc.titleAspergiloma pulmonar en paciente con síndrome de sobreposición: Reporte de casospa
dc.typeArtículo de revistaspa
dc.typeJournal articleeng
dc.identifier.doi10.24267/23897325.303
dc.identifier.eissn2539-2018
dc.identifier.urlhttps://doi.org/10.24267/23897325.303
dc.relation.bitstreamhttps://revistasdigitales.uniboyaca.edu.co/index.php/rs/article/download/303/450
dc.relation.citationeditionNúm. 1 , Año 2019 : Revista Investigación en Salud Universidad de Boyacáspa
dc.relation.citationendpage198
dc.relation.citationissue1spa
dc.relation.citationstartpage188
dc.relation.citationvolume6spa
dc.relation.ispartofjournalRevista Investigación en Salud Universidad de Boyacáspa
dc.relation.referencesSmith L, Denning D. Underlying conditions in chronic pulmonary aspergillosis, including simple aspergilloma. Eur. Respir. J. 2011; 44: 1–8. https://doi.org/10.1183/09031936.00054810spa
dc.relation.referencesGuyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011; 64 (3):380–2. https://doi.org/10.1016/j.jclinepi.2010.09.011spa
dc.relation.referencesPanackal AA, Li H, Kontoyiannis DP, et al. Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. Clin Infect Dis. 2010; 50 (8):1588–97. https://dx.doi.org/10.1086%2F652761spa
dc.relation.referencesMaturu VN, Agarwal R. Reversed halo sign: a systematic review. Respir Care 2014; 59:1440–9. https://doi.org/10.4187/respcare.03020spa
dc.relation.referencesPohl C, Jugheli L, Haraka F, Mfinanga E, Said K, Reither K. Pulmonary aspergilloma: a treatment challenge in sub-Saharan Africa, PLoS Negl. Trop. Dis. 2013; 7: 2352 - 10. https://doi.org/10.1371/journal.pntd.0002352spa
dc.relation.referencesValle J, González F, Álvarez J, Valdés L. La aspergilosis pulmonar invasiva en la enfermedad pulmonar obstructiva crónica. Rev Med Chile. 2010; 138: 612-620. https://scielo.conicyt.cl/pdf/rmc/v138n5/art13.pdfspa
dc.relation.referencesBustamante B, Denning D, Campos E. Serious fungal infections in Peru. Eur J Clin Microbiol Infect Dis. 2017; 36(6):943-948. https://doi.org/10.1007/s10096-017-2924-9spa
dc.relation.referencesKaya S, Gençalioğlu E, SönMez M, KökSal S. The importance of risk factors for the prediction of patients with invasive pulmonary aspergillosis. Rev Assoc Med BRAs 2017; 63(9):764-770. https://doi.org/10.1590/1806-9282.63.09.764spa
dc.relation.referencesJhun BW, Jung WJ, Hwang NY, Park HY, Jeon K, Kang E, et al. Risk factorsfor the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease. PLoS ONE. 2017; 12(11):1887-16. https://doi.org/10.1371/journal.pone.0188716spa
dc.relation.referencesPatterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2016; 63 (1): 1 – 60. https://doi.org/10.1093/cid/ciw326spa
dc.relation.referencesTaccone FS, Van den Abeele AM, Bulpa P, Misset B, Meersseman W, Cardoso T, et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Critical Care. 2015; 19:7 – 15. https://dx.doi.org/10.1186%2Fs13054-014-0722-7spa
dc.relation.referencesKovanda LL, Desai AV, Hope WW. Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis. J Pharmacokinet Pharmacodyn. 2017; 8: 1007 – 15. https://doi.org/10.1007/s10928-017-9509-1spa
dc.relation.referencesMetan G, Keklik M, Dinç G, Pala Ç, Yıldırım A, Saraymen B, et al. Performance of Galactomannan Antigen, Beta-d-Glucan, and Aspergillus-Lateral-Flow Device for the Diagnosis of Invasive Aspergillosis. Indian J Hematol Blood Transfus. 2017; 33(1):87-92. https://doi.org/10.1007/s12288-016-0653-3spa
dc.relation.referencesCruciani M, Mengoli C, Loeffler J, Donnelly P, Barnes R, Jones BL, et al. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cochrane Database Syst Rev. 2015; 7;(9): 551 – 21. https://doi.org/10.1002/14651858.CD009551.pub2spa
dc.relation.referencesAguado JM, Vázquez L, Fernández-Ruiz M, Villaescusa T, Ruiz-Camps I, Barba P, et al. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in highrisk hematological patients: a randomized controlled trial. Clin Infect Dis. 2015; 60:405–415. https://doi.org/10.1093/cid/ciu833spa
dc.relation.referencesSampsonas F, Kontoyiannis DP, Dickey BF, Evans SE. Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: a prospective 2-year study. Cancer 2011; 117:3424–33. https://dx.doi.org/10.1002%2Fcncr.25905spa
dc.relation.referencesMaertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, et al. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet 2016; 387:760–9. https://doi.org/10.1016/S0140-6736(15)01159-9spa
dc.relation.referencesLowes D, Al-Shair K, Newton PJ, Morris J, Harris C1 Rautemaa-Richardson R, et al. Predictors of mortality in chronic pulmonary aspergillosis. European Respiratory Journal. 2017; 49 (3): 160 – 15. https://doi.org/10.1183/13993003.01062-2016spa
dc.relation.referencesSalzer HJ, Cornely OA. Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis. European Respiratory Journal. 2017; 49 (16): 205 - 8. https://doi.org/10.1183/13993003.02520-2016spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.title.translatedPulmonary aspergiloma in patient with overposition syndrome: Case's reporteng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREFspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa


Ficheros en el ítem

FicherosTamañoFormatoVer
Revista Investig. Salud Univ. Boyacá-303.pdf243.3Kbapplication/pdfVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Revista Investigación en Salud Universidad de Boyacá - 2019
Excepto si se señala otra cosa, la licencia del ítem se describe como Revista Investigación en Salud Universidad de Boyacá - 2019